TABLE 3

Comparison of Ratio of Activity in Postalendronate vs. Baseline Scans in All Bony Metastatic Lesions Analyzed

Patient no.Lesions analyzed (n)Mean ratio of total counts in lesionsMean ratio of maximum counts in lesions
Initial postalendronate/baselineDelayed postalendronate/baselineInitial postalendronate/baselineDelayed postalendronate/baseline
150.970.90
231.251.161.252.63
320.901.110.951.13
451.642.041.221.33
550.930.950.930.97
651.571.52
751.131.20
830.970.750.660.53
921.240.970.980.77